In vitro effect of avermectins on lymphoid leukemia P-388 cells

Antibiotiki i Khimioterapiya

Volumn 44, Issue 6, 1999, Pages 16-20

  Mosin, V A ^a   Kruglyak, E B ^a   Sterlina, T S ^a   Korystov, Yu N ^a   Shaposhnikova, V V ^a   Kublik, L N ^a   Levitman, M Kh ^a   Viktorov, A V ^a   Drinyaev, V A ^a  

^a Farmbiomed Research Centre of Biology   (Russian Federation)

Author keywords

Apoptosis; Avermectins; Cell death; Cell division; Tumor cells

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIPARASITIC AGENT; AVERMECTIN; DRUG DERIVATIVE; INSECTICIDE; IVERMECTIN;

ANIMAL; ARTICLE; CELL CULTURE; DBA MOUSE; DRUG SCREENING; LYMPHATIC LEUKEMIA; MALE; METABOLISM; MOUSE; STREPTOMYCES;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTIPARASITIC AGENTS; DRUG SCREENING ASSAYS, ANTITUMOR; INSECTICIDES; IVERMECTIN; LEUKEMIA, LYMPHOCYTIC; MALE; MICE; MICE, INBRED DBA; STREPTOMYCES; TUMOR CELLS, CULTURED;

EID: 0032605644     PISSN: 02352990     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Burg R.W., Miller B.M., Baker E.E. et al. Avermectins, new family of potent anthelmintic agents: producing organism and fermentation. Antimicrob Agents Chemother 1979; 15:3:361-367.
2. Ostlind S.C., Long R. Insecticidal activity of the antiparasitic avermectins. Vet Rec 1979; 105:8:168.
3. Ivermectin and Abamectin. Campbell W.C. (ed.). New York: Springer-Verlag 1989; 363.
4. Putter I., MacConnel J.D., Preiser F.A. et al. Avermectins: novel insecticides, acaricides and nematocides from a soil microorganism. Experientia 1981; 37:963-964.
5. Milner A.E., Wang H., Gregory C.D. Analysis of apoptosis by flow cytometry. In: Flow cytometry applications in cell culture. M.Al-Rubeai, A.N. Emery (eds.). New-York: 1996; 193-209.
6. Dean P.N., Jeft J.H. Mathematical analysis of DNA distribution derived from flow microfluorometry. J Cell Biol 1974; 60: 523-527.
7. Alles A., Alley K., Barret J.C. et al. Apoptosis: a general comment. FASEB J 1991; 5: 2127-2128.
8. Maniatis T., Fritsch E., Sambroock J. Molecular cloning a laboratory mammal. New-York 1982.
9. Didier A., Loor F. The abamectin derivative ivermectin is a potent P-glycoprotein inhibitor. Anticancer Drugs 1996; 7: 745-751.